Ceribell to Participate in the William Blair 46th Annual Growth Stock Conference
CeriBell Sees ‘Early Innings' Growth as Hospital Accounts and Usage Hit Records
CeriBell, Inc. (CBLL) Presents at Bank of America Global Healthcare Conference 2026 Transcript
CeriBell, Inc. (CBLL) Q1 2026 Earnings Call Transcript
CeriBell Q1 Earnings Call Highlights
CeriBell, Inc. (CBLL) Reports Q1 Loss, Beats Revenue Estimates
Ceribell Reports First Quarter 2026 Financial Results
Ceribell to Participate in the Bank of America Securities 2026 Health Care Conference
Ceribell to Report First Quarter 2026 Financial Results on May 11, 2026
CeriBell Highlights 2026 Growth Plan at TD Cowen: 25%-29% Guide, VA Ramp, Delirium Pilot
CeriBell Conference: CFO Highlights 36% Revenue Growth, Expands EEG Platform to Pediatrics and Delirium
Brokerages Set CeriBell, Inc. (NASDAQ:CBLL) Target Price at $24.67
Allurion Technologies (NYSE:ALUR) & CeriBell (NASDAQ:CBLL) Head-To-Head Survey
Analyzing CeriBell (NASDAQ:CBLL) & Nephros (NASDAQ:NEPH)
CeriBell, Inc. (CBLL) Q4 2025 Earnings Call Transcript
CeriBell, Inc. (CBLL) Reports Q4 Loss, Beats Revenue Estimates
Ceribell Reports Fourth Quarter and Full Year 2025 Financial Results
Ceribell to Participate in Upcoming March Investor Conferences
Ceribell to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
Chuck Royce's Strategic Moves: Significant Reduction in Haemonetics Corp
CeriBell, Inc. (NASDAQ:CBLL) Receives $24.67 Average Price Target from Analysts
CeriBell (NASDAQ:CBLL) Director Josef Parvizi Sells 25,000 Shares of Stock
CeriBell Maps 2026 Growth at JPMorgan MedTech, Eyes Delirium and Stroke EEG Expansion
CeriBell, Inc. (CBLL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Xingjuan Chao Sells 79,000 Shares of CeriBell (NASDAQ:CBLL) Stock
CBLL Wins FDA Breakthrough Status for AI-Based LVO Stroke Detection
Ceribell Receives FDA Breakthrough Device Designation for LVO Stroke Detection and Monitoring Solution
Ceribell to Participate in the 44th Annual J.P. Morgan Healthcare Conference
CeriBell (NASDAQ:CBLL) CFO Scott Blumberg Sells 36,000 Shares of Stock
CeriBell (NASDAQ:CBLL) versus Stryker (NYSE:SYK) Financial Contrast
CBLL Gets FDA Consent for One-of-a-Kind Delirium Monitoring Solution
Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution
CeriBell, Inc. (NASDAQ:CBLL) Receives $25.17 Average Target Price from Brokerages
Ceribell Receives FDA 510(k) Clearance for Use of ClarityⓇ Algorithm for Neonates
Ceribell to Participate in the Piper Sandler 37th Annual Healthcare Conference
Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
CeriBell, Inc. (CBLL) Q3 2025 Earnings Call Transcript
CeriBell, Inc. (CBLL) Reports Q3 Loss, Beats Revenue Estimates
Ceribell Reports Third Quarter 2025 Financial Results
CeriBell, Inc. (CBLL) Expected to Beat Earnings Estimates: Should You Buy?
Ceribell to Report Third Quarter 2025 Financial Results on November 4, 2025
Medtech Leader Erica Rogers Joins Ceribell Board of Directors
CeriBell (CBLL) Q2 Revenue Jumps 38%
CeriBell, Inc. (CBLL) Q2 2025 Earnings Call Transcript
Ceribell Reports Second Quarter 2025 Financial Results
Ceribell to Report Second Quarter 2025 Financial Results on August 5, 2025
Ceribell Files Complaints Against Natus Medical Incorporated with the U.S. International Trade Commission and Federal Court in Delaware
Ceribell to Participate in the William Blair 45th Annual Growth Stock Conference
CeriBell, Inc. (CBLL) Q1 2025 Earnings Call Transcript
Ceribell Reports First Quarter 2025 Financial Results